Segment Information

12 Months Ended

Dec. 31, 2017

Aerie has one operating segment: the discovery, development and commercialization of pharmaceutical products that address unmet medical needs, focusing on glaucoma and other diseases of the eye. The Company's business is managed by a single management team, which reports to the Chief Executive Officer.

The following table presents total long-lived assets by location:



	DECEMBER 31,
(in thousands)	2017		2016
United States	$	6,609	$	5,161
Ireland	25,323		2,696
Total long-lived assets	$	31,932	$	7,857

Included in the above table is $4.2 million related to the value of the building leased for the Company’s build-out of its manufacturing plant in Ireland, which was recognized with a corresponding financing obligation, as the Company was deemed to be the owner of the building during the construction period under U.S. GAAP.